This infographic was funded by a medical educational grant from GSK, with the purpose of enhancing the fundamental understanding of oncology specialists of key data and the latest advancements in endometrial cancer care.
This content is not intended for US Healthcare Professionals.
This striking infographic provides a fascinating snapshot of the highlights in endometrial cancer research presented at the European Society of Medical Oncology (ESMO) Congress in October 2023.
Following the practice-changing findings from the key Phase III clinical studies, RUBY and NRG-GY018, revealed at the Society of Gynecologic Oncology (SGO) Annual Meeting in March 2023, data from ESMO 2023 captured in this infographic show that research in endometrial cancer continues at a pace.
